Forensic · IMMX
Immix Biopharma
Top signals
Atm Offering Active
424B5 ATM offering prospectus in the last 6 months (active dilution).
+12
Bear case preview · free
Immix Biopharma is managing an active ATM offering that creates ongoing shareholder dilution risk, a signal that typically emerges when companies need to preserve cash runway without committing to fixed capital raises. The 424B5 prospectus filing indicates the company is drawing on this mechanism to fund operations, which warrants monitoring of burn rate against cash position and the pace of drawdowns. Watch for any acceleration in ATM utilization or guidance revisions regarding cash runway over the next 6-12 weeks, as these often precede material adverse announcements in early-stage biotech firms.
↑ That's free. The $9 report goes deeper: every filing cited by accession number, 36-month chronology, what to watch next.
What we checked
✓ Red flags · 36mo
0 8-K events (bankruptcy, delisting, restatement, auditor, officer)
✓ Cyber · 12mo
0 Item 1.05 disclosures + buried-cyber scan
✓ Dilution · 24mo
1 S-3 + 424B5 filing
✓ Buried events
Item 8.01 sections classified for hidden material disclosures
$9
· one-time · emailed in under a minute
The full bear case on IMMX
Plain-English brief. Every signal cited to the exact SEC filing. 36-month chronology. What changes next.
✓ No-signals refund: if the algorithm finds zero red flags on your ticker, reply "refund" and I send the $9 back same day. No questions.
Not ready to buy? Get a free preview by email instead
We'll email you the top 3 signals on IMMX + a discount code for the full report. No subscription, no spam.
Score another ticker
Not investment advice. Every signal grounded in a specific SEC filing. Companies may respond via info@filingfirehose.com.